MiR-1287-5p, significantly downregulated in CRS patients, was shown to inhibit SNAI1 and HMGB1, thereby reducing pro-inflammatory cytokines (IL-6, IL-8, TNF-α) and EMT [57,58,59]. Here, IL6 is linked to congenital rubella syndrome.